Clinical Trials Browser

Interventional × Hemangioblastoma × Bevacizumab × Clear all

NCT01015300 2012-05-11

Bevacizumab (Avastin) in Unresectable/Recurrent Hemangioblastoma From Von-Hippel-Lindau Disease

Phase EARLY_PHASE1 Terminated

von Hippel-Lindau Disease, Hemangioblastoma